Related Experiment Video
Updated: May 21, 2026

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide
Published on: August 4, 2023
Standardization of Shirishavaleha with reference to physico-chemical characteristics
Shyamlal Singh Yadav1, Galib, B J Patgiri
1PhD Scholar, Department of Rasashastra and Bhaishajya Kalpana including Drug Research, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India.
Abstract:
Ten batches of Shirishavaleha were prepared by using Twak (Bark) and Sara (Heartwood) of Shirisha [Albizzia lebbeck Benth]. The adopted formulation was based on Shirisharishta of Bhaishajya Ratnavali. Though Shirisharishta has significant therapeutic effect in cases of Tamaka swasa, etc.; it has few difficulties during the pharmaceutical procedure like consuming long time, climatic influences etc. Considering these inconveniencies, the formulation composition has been converted in to Shirishavaleha. Avaleha has been prepared by using Twak and Sara of Shirisha. No significant differences were found in pharmaceutical aspects of both the samples of Shirishavaleha and the current method of preparation can be considered as standard. Attempts were also made to develop analytical profile of avaleha, which were almost similar in both the samples, except showing more Rf values in High Performance Thin Layer Chromatography profile of Sara group.
Related Concept Videos
Standard Solutions
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Drug Dissolution: Requirements and Profile Comparison
Urine: Physical and Chemical Properties
The concentration of these solutes varies, with urea being the most abundant nitrogenous waste product. Other solutes include sodium, chloride, potassium, phosphate,...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmaceutical Equivalents
